organization · Reporting owner
LILLY ENDOWMENT INC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ELI LILLY & Co
Report date May 06, 2026 · Filed May 07, 2026
Section 16 reporting ended · disclosed 2026-05-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 91,881,150 |
Ending reported balance
After 2026-05-06 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-06 · Sale · Disposed 13,620 · Balance 91,883,358 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $995.00 to $995.9963, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4. Row 2 · 2026-05-06 · Sale · Disposed 2,208 · Balance 91,881,150 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $996.00 to $996.46, inclusive. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $995.00 to $995.9963, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $996.00 to $996.46, inclusive.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 02, 2023 Filed May 3, 2023 19:13 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 13,832 | $410.56 | $5,678,879.75 |
DisclosureSEC source: 0001209191-23-026907 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,867,112 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $410.16 to $411.055, inclusive. Read SEC document |
| May 02, 2023 Filed May 3, 2023 19:13 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 17,513 | $409.71 | $7,175,233.72 |
DisclosureSEC source: 0001209191-23-026907 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,880,944 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $409.13 to $410.105, inclusive. Read SEC document |
| May 02, 2023 Filed May 3, 2023 19:13 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 10,353 | $408.72 | $4,231,478.16 |
DisclosureSEC source: 0001209191-23-026907 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,898,457 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $408.11 to $409.10, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| April 28, 2023 Filed May 1, 2023 18:32 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 5,915 | $403.77 | $2,388,281.81 |
DisclosureSEC source: 0001209191-23-026230 · doc4.xml · nonDerivative · entry 9 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,908,810 F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $403.27 to $404.235, inclusive. Read SEC document |
| April 28, 2023 Filed May 1, 2023 18:32 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 11,765 | $402.58 | $4,736,306.64 |
DisclosureSEC source: 0001209191-23-026230 · doc4.xml · nonDerivative · entry 8 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,914,725 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $402.24 to $403.205, inclusive. Read SEC document |
| April 28, 2023 Filed May 1, 2023 18:32 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 32,167 | $401.68 | $12,920,969.23 |
DisclosureSEC source: 0001209191-23-026230 · doc4.xml · nonDerivative · entry 7 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,926,490 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $401.24 to $402.235, inclusive. Read SEC document |
| April 28, 2023 Filed May 1, 2023 18:32 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 8,803 | $400.76 | $3,527,855.07 |
DisclosureSEC source: 0001209191-23-026230 · doc4.xml · nonDerivative · entry 6 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,958,657 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $400.19 to $401.185, inclusive. Read SEC document |
| April 28, 2023 Filed May 1, 2023 18:32 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 13,899 | $399.36 | $5,550,662.94 |
DisclosureSEC source: 0001209191-23-026230 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,967,460 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $399.02 to $399.98, inclusive. Read SEC document |
| April 28, 2023 Filed May 1, 2023 18:32 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 30,820 | $398.50 | $12,281,739.18 |
DisclosureSEC source: 0001209191-23-026230 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,981,359 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $398.02 to $399.01, inclusive. Read SEC document |
| April 28, 2023 Filed May 1, 2023 18:32 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 38,118 | $397.56 | $15,154,306.43 |
DisclosureSEC source: 0001209191-23-026230 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,012,179 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $397.02 to $398.01, inclusive. Read SEC document |
| April 28, 2023 Filed May 1, 2023 18:32 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 64,998 | $396.59 | $25,777,426.82 |
DisclosureSEC source: 0001209191-23-026230 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,050,297 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $396.02 to $397.01, inclusive. Read SEC document |
| April 28, 2023 Filed May 1, 2023 18:32 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 18,515 | $395.36 | $7,320,108.92 |
DisclosureSEC source: 0001209191-23-026230 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,115,295 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $395.00 to $396.995, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), and (9) to this Form 4. Read SEC document |
| April 06, 2023 Filed Apr 7, 2023 15:38 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 915 | $369.38 | $337,978.13 |
DisclosureSEC source: 0001209191-23-023712 · doc4.xml · nonDerivative · entry 6 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,133,810 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $369.275 to $369.435, inclusive. Read SEC document |
| April 06, 2023 Filed Apr 7, 2023 15:38 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 46,903 | $368.63 | $17,289,759.08 |
DisclosureSEC source: 0001209191-23-023712 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,134,725 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $368.275 to $369.26, inclusive. Read SEC document |
| April 06, 2023 Filed Apr 7, 2023 15:38 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 27,720 | $367.77 | $10,194,473.52 |
DisclosureSEC source: 0001209191-23-023712 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,181,628 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $367.275 to $368.27, inclusive. Read SEC document |
| April 06, 2023 Filed Apr 7, 2023 15:38 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 16,321 | $366.80 | $5,986,510.16 |
DisclosureSEC source: 0001209191-23-023712 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,209,348 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $366.27 to $367.265, inclusive. Read SEC document |
| April 06, 2023 Filed Apr 7, 2023 15:38 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 22,196 | $365.70 | $8,117,143.79 |
DisclosureSEC source: 0001209191-23-023712 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,225,669 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $365.265 to $366.23, inclusive. Read SEC document |
| April 06, 2023 Filed Apr 7, 2023 15:38 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 16,242 | $364.98 | $5,927,956.43 |
DisclosureSEC source: 0001209191-23-023712 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,247,865 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $364.265 to $365.26, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5) and (6) to this Form 4. Read SEC document |
| April 05, 2023 Filed Apr 6, 2023 17:21 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 9,444 | $364.21 | $3,439,618.13 |
DisclosureSEC source: 0001209191-23-023555 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,264,107 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $364.00 to $364.385, inclusive. Read SEC document |
| April 05, 2023 Filed Apr 6, 2023 17:21 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 60,259 | $363.24 | $21,888,298.38 |
DisclosureSEC source: 0001209191-23-023555 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,273,551 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $363.00 to $363.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| April 03, 2023 Filed Apr 4, 2023 15:53 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 100 | $351.50 | $35,150.00 |
DisclosureSEC source: 0001209191-23-022522 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,333,810 Read SEC document |
| April 03, 2023 Filed Apr 4, 2023 15:53 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 116,614 | $350.88 | $40,917,870.16 |
DisclosureSEC source: 0001209191-23-022522 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,333,910 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.50 to $351.47, inclusive. Read SEC document |
| April 03, 2023 Filed Apr 4, 2023 15:53 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 93,286 | $350.01 | $32,650,566.43 |
DisclosureSEC source: 0001209191-23-022522 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,450,524 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $349.50 to $350.4975, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 14:25 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 260 | $343.54 | $89,320.40 |
DisclosureSEC source: 0001209191-23-021975 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,543,810 Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 14:25 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 45,143 | $342.83 | $15,476,284.40 |
DisclosureSEC source: 0001209191-23-021975 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,544,070 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $342.50 to $343.39, inclusive. Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 14:25 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 159,597 | $341.78 | $54,546,264.68 |
DisclosureSEC source: 0001209191-23-021975 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,589,213 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $341.50 to $342.49, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| March 24, 2023 Filed Mar 27, 2023 14:31 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 18,024 | $336.61 | $6,067,022.59 |
DisclosureSEC source: 0001209191-23-021155 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,748,810 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $336.50 to $336.79, inclusive. Read SEC document |
| March 24, 2023 Filed Mar 27, 2023 14:31 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 181,976 | $335.75 | $61,097,532.12 |
DisclosureSEC source: 0001209191-23-021155 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,766,834 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $335.50 to $336.495, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 17:15 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 5,895 | $374.56 | $2,208,037.10 |
DisclosureSEC source: 0001209191-22-059567 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,948,810 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $374.04 to $374.965, inclusive. Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 17:15 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 16,930 | $373.41 | $6,321,746.65 |
DisclosureSEC source: 0001209191-22-059567 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,954,705 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $373.00 to $373.985, inclusive. Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 17:15 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 18,464 | $372.46 | $6,877,082.98 |
DisclosureSEC source: 0001209191-22-059567 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,971,635 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $372.00 to $372.99, inclusive. Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 17:15 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 7,800 | $371.45 | $2,897,325.60 |
DisclosureSEC source: 0001209191-22-059567 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,990,099 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $371.00 to $371.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 16:29 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 500 | $375.18 | $187,587.50 |
DisclosureSEC source: 0001209191-22-059288 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,997,899 Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 16:29 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 4,162 | $374.32 | $1,557,936.49 |
DisclosureSEC source: 0001209191-22-059288 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,998,399 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $374.005 to $374.785, inclusive. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 16:29 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 6,184 | $373.39 | $2,309,037.58 |
DisclosureSEC source: 0001209191-22-059288 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,002,561 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $373.00 to $373.935, inclusive. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 16:29 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 5,759 | $372.32 | $2,144,196.64 |
DisclosureSEC source: 0001209191-22-059288 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,008,745 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $372.00 to $372.95, inclusive. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 16:29 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 144,306 | $371.34 | $53,586,734.35 |
DisclosureSEC source: 0001209191-22-059288 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,014,504 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $371.00 to $371.995, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4. Read SEC document |
| November 07, 2022 Filed Nov 8, 2022 18:45 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 2,787 | $366.42 | $1,021,220.90 |
DisclosureSEC source: 0001209191-22-056062 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,158,810 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $366.04 to $366.90, inclusive. Read SEC document |
| November 07, 2022 Filed Nov 8, 2022 18:45 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 9,187 | $365.39 | $3,356,847.12 |
DisclosureSEC source: 0001209191-22-056062 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,161,597 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $365.01 to $365.99, inclusive. Read SEC document |
| November 07, 2022 Filed Nov 8, 2022 18:45 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 19,415 | $364.47 | $7,076,223.88 |
DisclosureSEC source: 0001209191-22-056062 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,170,784 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $364.01 to $365.00, inclusive. Read SEC document |
| November 07, 2022 Filed Nov 8, 2022 18:45 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 17,916 | $363.54 | $6,513,164.72 |
DisclosureSEC source: 0001209191-22-056062 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,190,199 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $363.00 to $363.99, inclusive. Read SEC document |
| November 07, 2022 Filed Nov 8, 2022 18:45 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 14,280 | $362.30 | $5,173,586.88 |
DisclosureSEC source: 0001209191-22-056062 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,208,115 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $362.00 to $362.995, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4) and (5) to this Form 4. Read SEC document |
| November 04, 2022 Filed Nov 7, 2022 19:34 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 686 | $365.20 | $250,527.20 |
DisclosureSEC source: 0001209191-22-055915 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,222,395 Read SEC document |
| November 04, 2022 Filed Nov 7, 2022 19:34 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 650 | $362.26 | $235,469.00 |
DisclosureSEC source: 0001209191-22-055915 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,223,081 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $362.02 to $362.34, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 03, 2022 Filed Nov 4, 2022 16:21 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 133,948 | $362.08 | $48,499,891.84 |
DisclosureSEC source: 0001209191-22-055740 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,223,731 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $362.00 to $362.645, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 16:16 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 6,131 | $362.07 | $2,219,851.17 |
DisclosureSEC source: 0001209191-22-055450 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,357,679 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $362.00 to $362.25, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| October 21, 2022 Filed Oct 24, 2022 20:10 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 2,300 | $342.15 | $786,951.90 |
DisclosureSEC source: 0001209191-22-054393 · doc4.xml · nonDerivative · entry 8 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,363,810 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $342.06 to $342.24, inclusive. Read SEC document |
| October 21, 2022 Filed Oct 24, 2022 20:10 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 28,902 | $341.33 | $9,865,177.46 |
DisclosureSEC source: 0001209191-22-054393 · doc4.xml · nonDerivative · entry 7 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,366,110 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $341.04 to $342.0255, inclusive. Read SEC document |
| October 21, 2022 Filed Oct 24, 2022 20:10 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 16,568 | $340.80 | $5,646,374.40 |
DisclosureSEC source: 0001209191-22-054393 · doc4.xml · nonDerivative · entry 6 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,395,012 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $340.035 to $341.03, inclusive. Read SEC document |
| October 21, 2022 Filed Oct 24, 2022 20:10 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 7,465 | $339.37 | $2,533,389.59 |
DisclosureSEC source: 0001209191-22-054393 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,411,580 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $339.035 to $340.02, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.